Centessa Pharmaceuticals (CNTA)
(Delayed Data from NSDQ)
$14.84 USD
-0.42 (-2.75%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $14.84 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/27/25 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.37 |
Last EPS Surprise | 11.90% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.60 |
Next Year | -1.50 |
EPS (TTM) | -1.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 6.85M | 0.00M | 6.85M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.39 | -1.60 | -1.50 |
# of Estimates | 5 | 3 | 5 | 5 |
Most Recent Consensus | -0.41 | -0.36 | -1.56 | -1.57 |
High Estimate | -0.35 | -0.36 | -1.50 | -1.09 |
Low Estimate | -0.71 | -0.42 | -1.87 | -1.76 |
Year ago EPS | -0.38 | -0.38 | -1.57 | -1.60 |
Year over Year Growth Est. | -18.42% | -2.63% | -1.91% | 6.13% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.39 | -1.60 | -1.50 |
7 Days Ago | -0.45 | -0.39 | -1.60 | -1.50 |
30 Days Ago | -0.45 | -0.38 | -1.60 | -1.50 |
60 Days Ago | -0.46 | -0.38 | -1.62 | -1.57 |
90 Days Ago | -0.47 | -0.37 | -1.68 | -1.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.36 | -1.60 | -1.57 |
Zacks Consensus Estimate | -0.45 | -0.39 | -1.60 | -1.50 |
Earnings ESP | 0.00% | 6.90% | 0.00% | -4.67% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.37 | -0.40 | -0.38 | -0.38 | NA |
Estimate | -0.42 | -0.38 | -0.41 | -0.44 | NA |
Difference | 0.05 | -0.02 | 0.03 | 0.06 | 0.03 |
Surprise | 11.90% | -5.26% | 7.32% | 13.64% | 6.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more